Navigation Links
DNA Therapeutics Closes 2.2 Million EUR Series A Financing Round
Date:1/29/2009

on at early stage in France and in Europe, and that shares our business vision and values the potential of our drug development based on our unique proprietary siDNA technology. This financing will allow DNA Therapeutics to move ahead with an aggressive timeline for the preclinical development of Dbait which will enter into phase I/II clinical trial by the end of 2010."

"Since January 2006, we have been carrying out fundamental work consisting of creating and shaping our company portfolio to meet SEFTI's objectives. This effort has resulted in an original portfolio companies, mainly in France and Switzerland, close to clinical stage, and attractive to big biotech, pharmaceutical and medical device companies. Adding DNA Therapeutics, which develops a breakthrough treatment in oncology, to SEFTI's portfolio companies, is in line with our innovative investment strategy. Today, SGAM SEFTI has already invested, or is ready to invest in near term, more than half of the fund's commitments," said Beatrice Denys, manager of the fund. "The life of the fund is entering a second phase in which one of our priorities will be to endeavor to demonstrate the validity of our investment choices, notably through the emphasis placed on organizing output," added Eric Viaud, exclusive advisor of SEFTI.

About DNA Therapeutics

DNA Therapeutics SA (http://www.dna-therapeutics.com) headquartered in the Genopole biocluster (Evry, France) was founded in June 2006. Its original siDNA technology consists in interfering with DNA repair pathways that cancer cells use to resist radiotherapy and chemotherapy. Its lead product, Dbait, will be first administered locally in combination with radiotherapy in selected indications where radiotherapy is used as standard of care but fails due to radio-resistance. After its first clinical validation, the systemic administration of Dbait
'/>"/>

SOURCE DNA Therapeutics SA
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update
2. Duska Therapeutics Completes Corporate Name Change to Cordex Pharma
3. Phico Therapeutics Receives GBP1 Million Award From the Wellcome Trust to Take Anti-MRSA Nasal Product Through Early Clinical Trials
4. Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission
5. Cephalon Signs Option Agreement to Acquire Ception Therapeutics
6. Amicus Therapeutics Announces Positive Progress of Three Lead Clinical Programs and General Outlook for 2009
7. Cara Therapeutics Initiates Phase II Proof-Of-Concept Trial of Novel Analgesic in Acute Post-Operative Pain
8. ExonHit Therapeutics Expands Strategic Collaboration With Allergan
9. Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline in Renal Function and Arterial Stiffness in Older Adults
10. Synvista Therapeutics Announces First Dosing of SYI-2074 in Clinical Trial for Psoriasis
11. Halozyme Therapeutics Begins Phase 1 Clinical Trial of Bisphosphonate Administered With rHuPH20 Enzyme
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... , July 22, 2014  ConvaTec, a privately-held medical ... Clerkin has been appointed chief financial officer of ... Clerkin was previously executive vice president and chief financial ... -based biotechnology company.  Mr. Clerkin was part of a ... Elan, culminating in its sale to Perrigo, a pharmaceutical ...
(Date:7/22/2014)... 2014 The steady decline of pharmaceutical ... previously rep-friendly specialties, according to the spring 2014 ... firm ZS Associates.      AccessMonitor™ aggregates ... sales teams. The report examines how often approximately ... pharmaceutical sales reps who visit their offices. ...
(Date:7/22/2014)... 2014 WuXi PharmaTech (Cayman) Inc. (NYSE: ... outsourcing company with operations in China ... that it will release financial results for the second quarter ... Wednesday, August 13, 2014 (which will be Thursday morning, August ... on the investor relations section of the Company,s website at ...
Breaking Medicine Technology:ConvaTec Names Nigel Clerkin Chief Financial Officer 2Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 2Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 3Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 4Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 5WuXi PharmaTech Schedules Second-Quarter 2014 Earnings Release 2
... 10, 2011 USANA Health Sciences, Inc. (NYSE: ... nutritional gaps are common in the average American diet and ... those gaps.  However, USANA scientists and advising physicians caution that ... Dietary Guidelines for Americans, 2010 and ...
... MATEO, Calif., Feb. 10, 2011 AlphaDetail, a leader ... biotech industries, reported a 30% increase in revenue in ... time in the company,s history. "Our clients ... provides the marketing research solutions that get at the ...
Cached Medicine Technology:USDA Recognizes Benefit of Supplements in New Dietary Guidelines But Doesn't Go Far Enough 2AlphaDetail Revenue Soars 30% in 2010 2
(Date:7/22/2014)... July 22, 2014 Alan Tonelson of ... young child. While most kids outgrow the inhibiting speech ... He is among the three million people in the ... mild to severe. Throughout his youth, he participated in ... sessions and visits with private speech-and-language pathologists. None helped ...
(Date:7/22/2014)... "The Big Secrets: Ten Things Every Young Person Should Know ... young people can read. , But be careful! What’s in this ... people have been living with all their lives. And If the ... sex to death, this self-help book deals directly with social reality ... it like it is. , Tune in to “The Big Secrets” ...
(Date:7/22/2014)... 2014 One woman who looked at diet ... 20 pounds. Unfortunately, the weight loss came at a price ... of her time using the pill, and says her personality ... and insomnia as a result of the caffeine content of ... the age of 37 because of a diet pill she ...
(Date:7/22/2014)... Industry-leading health business information publisher Atlantic Information Services ... Pharmacy Trends and Strategies: 2014 , the latest edition ... of the current state of the specialty pharmacy industry. ... , Specialty drugs on the exchanges ... details of coinsurance levels by plan, by metal tier ...
(Date:7/22/2014)... Cumberland Pediatric Dentistry and Orthodontics stresses ... anxiety-free dental care for children, while maintaining the most ... care. , The orthodontic team is committed to ... adults and those with special needs. Whether a child ... unique care, such as cleft palate, Cumberland Pediatric Dentistry ...
Breaking Medicine News(10 mins):Health News:New Steps in the “Ballet of Speech” Create Life-Changing Possibilities for People Who Stutter 2Health News:New Steps in the “Ballet of Speech” Create Life-Changing Possibilities for People Who Stutter 3Health News:New Steps in the “Ballet of Speech” Create Life-Changing Possibilities for People Who Stutter 4Health News:Strategic Book Publishing & Rights Agency Announces the Release of its Newest Title, “The Big Secrets: Ten Things Every Young Person Should Know About and Why” 2Health News:SlimPlate System Urge Women to Shun Controversial Weight Loss Pills for Healthier Methods Like Portion Control 2Health News:Latest Edition of Annual Book Provides Comprehensive Overview of the Specialty Pharmacy Arena 2Health News:Cumberland Pediatric Dentistry and Orthodontics of Clarksville Welcomes Dr. Peter Wojtkiewicz, Pediatric Orthodontist 2Health News:Cumberland Pediatric Dentistry and Orthodontics of Clarksville Welcomes Dr. Peter Wojtkiewicz, Pediatric Orthodontist 3
... new study published in the journal, Molecular Psychiatry suggested that ... susceptible to sleepwalking. Sleepwalking is a complex disorder and affects ... cent of adults. Though the condition is harmless, it may ... to others. Scientists examined a family of genes known as ...
... called C150T transition in people over 100 years old, a ... mutation was found in the mitochondrial DNA of white blood ... centenarians. The researchers found that 17 per cent of the ... 3.4 per cent of 117 control subjects under the age// ...
... all newly-diagnosed lung cancer cases. Smoking inflicts serious damage to ... quit, as it takes time for the tissue to recover. ... in the form of loss of a gene that could ... Texas have now shown that a close chemical relative of ...
... of the National Academy of Science, recently published a study ... that a brain protein called WAVE-1 may play a key ... found throughout the brain and plays an important role in ... that were produced, without the WAVE-1// protein, by the researchers ...
... by Juliette van den Dolder at the University of Nijmegen ... bone fractures with the help of specially prepared titanium mesh ... into a bone fracture in a rat. They allowed bone ... bone growth being stimulated by the bone// marrow cells. They ...
... it is no term to be happy about, because this ... could affect those individuals whose work or lifestyle demands them ... for a long time without a break could cause blood ... the lungs with possible fatal consequences. This condition is identical ...
Cached Medicine News:Health News:Bones repair themselves with bone marrow cells 2
... Mumps IgG Enzyme- linked Immunosorbent Assay (ELISA) ... determination of IgG antibody to Mumps virus ... be used for the determination of immune ... be used to demonstrate seroconversion or a ...
The DSL-05-10-MUG Mumps IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgG-class antibodies to Mumps Virus in human serum. This assay is intended for in...
With BareWire technology, the wire crosses the lesion first, independent of the filter and delivery catheter. All other actions, including filter placement and retrieval, balloon dilatations, and ste...
... Ultra Laboratory has been uniquely designed ... single facility to integrated networks spanning ... to management reporting and accounts receivable, ... precise laboratory management. All system modules ...
Medicine Products: